Turner syndrome and clinical treatment
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Turner syndrome (TS) is a genetic disorder associated with abnormalities of the X chromosome, occurring in about 50 per 100,000 liveborn girls. TS is usually associated with reduced adult height, gonadal dysgenesis and thus insufficient circulating levels of female sex steroids leading to premature ovarian failure and infertility. The average intellectual performance is within the normal range. New insight into genetics, epidemiology, cardiology, endocrinology and metabolism from a number of recent studies will be included in this review. SOURCES OF DATA: For this review we concentrated on all papers published on TS with special emphasis on the most recent literature. Also papers relating to cardiology, especially aortic dissection, paediatrics and the effects of estradiol in other conditions were considered. The main source was PubMed and the major endocrinology and cardiology journals. AREAS OF AGREEMENT: Treatment with growth hormone (GH) during childhood and adolescence allows a considerable gain in adult height. SHOX deficiency explains some of the phenotypic characteristics in TS, principally short stature. Puberty has to be induced in most cases, and female sex hormone replacement therapy (HRT) is given during adult years. Morbidity and mortality is increased, especially due to the risk of dissection of the aorta and other cardiovascular (CV) diseases, as well as the risk of type 2 diabetes, osteoporosis and thyroid disease. AREAS OF CONTROVERSY: The proper dose of HRT with female sex steroids has not been established, and, likewise, benefits and/or drawbacks from HRT have not been thoroughly evaluated. In most countries it seems that the transition period from paediatric to adult care is especially vulnerable and the proper framework for transition has not been established. Today, most treatment recommendations are based on expert opinion and are unfortunately not evidence based, although more areas, such as GH treatment for increasing height, are well founded. GROWING POINTS: The description of adult life with TS has been broadened and medical, social and psychological aspects are being added at a compelling pace. AREAS TIMELY FOR DEVELOPING RESEARCH: Proper care during adulthood should be studied, since most morbidity potentially is amenable to proper care. Especially, interventional strategy and follow-up with respect to congenital CV malformations, as well as secondary CV disease, have to be developed and new treatment algorithms have to be studied. In summary, TS is a condition associated with a number of diseases and conditions, which need the attention of a multi-disciplinary team.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nielsen, J., & Wohlert, M. (1991) · Human Genetics · doi:10.1007/bf01213097 · Cited by 1,193 · cited 1×
“Hypogonadism has pervasive effects, affecting (1) different hormone levels, ( 2 ) CV features, (3) metabolic features and (4) features related to sex hormones, such as infertility.”
BackgroundPrevalence, incidence, diagnostic delay, and mortality in Turner syndrome
Stochholm, K., Juul, S., Juel, K., Naeraa, R. W., & Højbjerg Gravholt, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0558 · Cited by 652
Major Vascular Anomalies in Turner Syndrome: Prevalence and Magnetic Resonance Angiographic Features
Ho, V. B., Bakalov, V. K., Cooley, M., Van, P. L., Hood, M. N., Burklow, T. R., & Bondy, C. A. (2004) · Circulation · doi:10.1161/01.cir.0000142290.35842.b0 · Cited by 316
(2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2187 · Cited by 256
Gravholt, C. H., Naeraa, R. W., Nyholm, B., Gerdes, L. U., Christiansen, E., Schmitz, O., & Christiansen, J. S. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1062 · Cited by 204
Delayed diagnoses of Turner's syndrome: proposed guidelines for change
Sävendahl, L., & Davenport, M. L. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.107390 · Cited by 180 · cited 1×
“Hypogonadism has pervasive effects, affecting (1) different hormone levels, (2) CV features, ( 3 ) metabolic features and (4) features related to sex hormones, such as infertility.”
BackgroundHypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome
Elsheikh, M., Casadei, B., Conway, G. S., & Wass, J. A. H. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01154.x · Cited by 173
Hypothyroidism is common in Turner syndrome: results of a five-year follow-up
El-Mansoury, M., Bryman, I., Berntorp, K., Hanson, C., Wilhelmsen, L., & Landin-Wilhelmsen, K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1262 · Cited by 166
Turner syndrome: evaluation of prenatal diagnosis in 19 European registries
Baena, N., De Vigan, C., Cariati, E., Clementi, M., Stoll, C., Caballín, M. R., Guitart, M., & The Euroscan working group (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30092 · Cited by 160 · cited 1×
“Hypogonadism has pervasive effects, affecting ( 1 ) different hormone levels, (2) CV features, (3) metabolic features and (4) features related to sex hormones, such as infertility.”
BackgroundDavenport, M. L., Crowe, B. J., Travers, S. H., Rubin, K., Ross, J. L., Fechner, P. Y., Gunther, D. F., Liu, C., Geffner, M. E., Thrailkill, K., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2874 · Cited by 147
Cited by
Etiologies and Early Diagnosis of Short Stature and Growth Failure in Children and Adolescents
Rogol, A. D., & Hayden, G. F. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.02.027 · Cited by 186
Mortensen, K. H., Hjerrild, B. E., Stochholm, K., Andersen, N. H., Sørensen, K. E., Lundorf, E., Hørlyck, A., Pedersen, E. M., Christiansen, J. S., & Gravholt, C. H. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-24 · Cited by 99
Mortensen, K. H., Hjerrild, B. E., Andersen, N. H., Sørensen, K. E., Hørlyck, A., Pedersen, E. M., Lundorf, E., Christiansen, J. S., & Gravholt, C. H. (2010) · Cardiology in the Young · doi:10.1017/s1047951110000041 · Cited by 93
“That is, milder forms of aortopathy could easily be overlooked if we uncritically compare aortic measurements in Turner syndrome to those acquired in taller healthy women who are unaffected by hypertension, metabolic syndrome, or other well-known risk factors reported to be associated with the syndrome.(21) Unfortunat…”
BackgroundSelf-citationLinglart, A., Cabrol, S., Berlier, P., Stuckens, C., Wagner, K., de Kerdanet, M., Limoni, C., Carel, J.-C., Chaussain, J.-L., & _, _. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1048 · Cited by 61
Turner syndrome in girls presenting with coarctation of the aorta
Eckhauser, A., South, S. T., Meyers, L., Bleyl, S. B., & Botto, L. D. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.08.002 · Cited by 50
Fiot, E., Zénaty, D., Boizeau, P., Haignere, J., Dos Santos, S., Léger, J., _, _., _, _., Carel, J. C., Cabrol, S., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0878 · Cited by 48
The role of the SHOX gene in the pathophysiology of Turner syndrome
Oliveira, C. S., & Alves, C. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.06.005 · Cited by 49
“Besides the classic karyotype 45,X (present in 40--60% of the cases), other karyotype abnormalities can occur in TS, such as: duplications of the long arm (q) of the X chromosome with concurrent loss of short arm (p) to constitute a isochromosome (isoXq); ring formation (rX), deletions of the short and long arm of the…”
BackgroundNew insights on diabetes in Turner syndrome: results from an observational study in adulthood
Ibarra-Gasparini, D., Altieri, P., Scarano, E., Perri, A., Morselli-Labate, A. M., Pagotto, U., Mazzanti, L., Pasquali, R., & Gambineri, A. (2018) · Endocrine · doi:10.1007/s12020-017-1336-z · Cited by 31
Left ventricular hypertrophy in Turner syndrome: a prospective echocardiographic study
Mortensen, K. H., Gravholt, C. H., Hjerrild, B. E., Stochholm, K., & Andersen, N. H. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01754.x · Cited by 15
Self-citationKrikščiūnienė, R., Navickaitė, I., Ereminienė, E., Lukoševičius, S., Žilaitienė, B., & Verkauskienė, R. (2019) · International Journal of Endocrinology · doi:10.1155/2019/9258726 · Cited by 4
“Morbidity and mortality of TS patients are high, particular due to cardiovascular disorders [2].”
Background
Metadata
- Authors
- Hjerrild, B. E., Mortensen, K. H., & Gravholt, C. H.
- Venue
- British Medical Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-18
- Volume
- 86
- Issue
- 1
- Pages
- 77-93
- ISSN
- 0007-1420 (ISSN-L)
- 1471-8391
- OpenAlex
- W2120137153
- Cited by
- 116
- References
- 21
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.